Cardiopulmonary Monitoring in Lung Cancer Patients Receiving Combined Thoracic Radiotherapy and Immunotherapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bo Lu, MD
Chair, Department of Radiation Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Missouri - Ellis Fischel Cancer Center
Columbia, Missouri, United States
Bo Lu, MDGregory Biedermann, MDRuobing Xue, MDRecruiting - Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
Salma Jabbour, MDNot, yet, recruiting - University of Rochester Medical Center
Rochester, New York, United States
Yuhchyau Chen, MD, PhDNot, yet, recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 Apr 2024
- Primary completion
- 19 Apr 2028
- Completion
- 19 Apr 2030
- Last update posted
- 19 Jun 2025
- Registered enrollment
- 125
- Registry id
- NCT06410300
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.